US4593032A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Terguride as antihypertensive
Assignee: Bayer Pharma AG
•
Filing: 1985-03-15
•
Granted: 1986-06-03
•
Expires: 2005-03-15
Abstract
Abstract Terguride and its physiologically compatible salts have been discovered to be useful in the treatment of essential hypertonia, e.g., in humans, e.g., in doses of 0.1-1.0 mg/day.
Inventors
- 👤 Wolfgang Kehr
- 👤 Gertrud Schroder
- 👤 Gunter Stock
- 👤 Helmut Wachtel
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 16:25
CPC Classifications
C; C07; C07D; C07D457/00; C07D457/10; C07D457/12; A; A61; A61P; A61P9/00; A61P9/12
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
31 words
A method of achieving an antihypertensive effect in a patient comprising administering to a patient suffering from hypertension an antihypertensively effective amount of terguride or a pharmacologically acceptable acid salt thereof.
Claim 2
Independent Claim
31 words
A method of achieving an antihypertensive effect in a patient comprising administering to a patient suffering from hypertension an antihypertensively effective amount of terguride or a pharmacologically acceptable acid salt thereof.
Claim 3
Dependent Claim
13 words
A method of claim 1 wherein the amount of terguride is 0.1-1.0 mg/day.
Claim 4
Dependent Claim
10 words
A method of claim 1 wherein the administration is orally.
Claim 5
Dependent Claim
13 words
A method of claim 1 wherein the administration is subcutaneously, intramuscularly or intravenously.
Claim 6
Dependent Claim
8 words
A method of claim 1 comprising administering terguride.
Claim 7
Dependent Claim
13 words
A method of claim 1 comprising administering a pharmacologically acceptable salt of terguride.
Claim 8
Dependent Claim
22 words
A method of claim 3 wherein terguride or a salt thereof is administered as a tablet, capsule, dragee, pill, suspension or solution.
Claim 9
Independent Claim
34 words
A method of treating idiomatic hypertonia in a patient with substantially no emesis as a side effect comprising administering to the patient an antihypertensively effective amount of terguride or a pharmacologically acceptable salt thereof.
Claim 10
Independent Claim
34 words
A method of treating idiomatic hypertonia in a patient with substantially no emesis as a side effect comprising administering to the patient an antihypertensively effective amount of terguride or a pharmacologically acceptable salt thereof.
References Cited (Backward Citations)
DE2238540A1
Cited
DE3129714A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-06-02 | 1989-12-02 | 1990-06-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-06-02 | 1993-12-02 | 1994-06-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-06-02 | 1997-12-02 | 1998-06-03 | $7700.00 | Window Closed / Lapsed |